HCA Holdings Inc., the largest for-profit hospital operator in the U.S., said power morcellation for uterine fibroid removal will no longer be performed at its facilities, after the procedure was linked to the spread of cancer. HCA’s decision follows new warnings regarding morcellator use issued by the U.S. Food and Drug Administration.
Free Morcellator Cancer Lawsuit Evaluation: If you or a loved one was diagnosed with cancer after undergoing surgery with a laparoscopic power morcellator, you should contact our law firm immediately. You may be entitled to compensation by filing a suit against the manufacturer of the morcellator and we can help.
What’s the Problem?
HCA’s decision to ban power morcellators marks one of the first major shifts concerning the controversial medical devices since the FDA’s Nov. 24 warning. The agency said morcellators should not be used in the “vast majority” of women undergoing surgery for fibroid removal because the procedure could spread undetected cancers called sarcomas beyond the uterus.
“There is no reliable way to determine if a uterine fibroid is cancerous prior to removal,” said William Maisel, M.D., M.P.H., deputy director for science and chief scientist at the FDA’s Center for Devices and Radiological Health. “Patients should know that the FDA is discouraging the use of laparoscopic power morcellation for hysterectomy or myomectomy, and they should discuss the risks and benefits of the available treatment options with their health care professionals.”
Prior to the FDA’s most recent warning, HCA advised surgeons follow the agency’s previous guidance, which discouraged power morcellation for fibroid removal. It wasn’t immediately clear if HCA’s physicians had been using morcellators regularly. The company’s new ban on morcellators is currently underway, and applies to all its approximately 160 hospitals and 115 surgery centers in 20 states around the country.
Insurance Companies Call for Tighter Regulations on Power Morcellation
America’s Health Insurance Plans, a trade group, sent a letter to Senator Bob Casey (D-PA) on April 13 regarding problems with how power morcellators are approved and monitored, according to the Wall Street Journal. Casey wrote the group in part to gauge the industry’s stance on power morcellators, and to see if health plans track adverse events associated with the devices. Click here to learn more.
Do I Have a Morcellator Cancer Lawsuit?
The Medical Device Litigation Group at our law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in laparoscopic power morcellator lawsuits. We are handling individual litigation nationwide and currently accepting new morcellation cancer cases in all 50 states.
Free Morcellator Cancer Lawsuit Evaluation: Again, if you or a loved one was diagnosed with cancer after undergoing surgery with a laparoscopic power morcellator, you should contact our law firm immediately. You may be entitled to compensation by filing a Morcellation Cancer Suit and we can help.